跳至主要内容
临床试验/NCT01012232
NCT01012232已完成4 期

The Volume-concentration Relationship of Analgesic Efficacy With Intra-capsular Local Anesthetic in Total Knee Arthroplasty: a Randomized, Double-blind, Cross-over Trial.

Lundbeck Foundation1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
48
试验地点
1
主要终点
postoperative pain

研究概览

简要总结

In a randomized, double-blind, cross-over trial, 48 patients scheduled for total knee arthroplasty with placement of an intracapsular catheter will be randomized to receive bolus injection of ropivacaine in high volume/low concentration (20 ml, 5 mg/mL) or low volume/high concentration (10 mL, 10 mg/mL) 6 and 24 hours postoperatively, and pain will be assessed at rest and with mobilization for 2 hours after injections.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Scheduled for total knee arthroplasty
  • Able to give informed oral and written consent to participate

排除标准

  • Treatment with opioids or steroids, rheumatoid arthritis or other immunological diseases
  • History of stroke or any neurological or psychiatric disease potentially influencing pain perception (e.g. depression, diabetic neuropathy etc.)
  • Allergies to any of the drugs administered.

研究组 & 干预措施

low volume local anesthetic

Active Comparator

bolus injection of local anesthetic in low volume/high concentration (10 mL, 10 mg/mL)

干预措施: 10 mL ropivacaine 10 mg/mL (Drug)

high volume local anesthetic

Experimental

bolus injection of ropivacaine in high volume/low concentration (20 ml, 5 mg/mL)

干预措施: 20 mL ropivacaine 5 mg/mL (Drug)

结局指标

主要结局

postoperative pain

时间窗: 32 hours postoperative

次要结局

未报告次要终点

研究者

发起方
Lundbeck Foundation
申办方类型
Other

研究点 (1)

Loading locations...

相似试验